| STAYBLE THERAPEUTICS AB |
| Schweden |
| Gesundheit |
| SE0013513652 / A2P1F3 |
| 4K4 (Frankfurt) |
| FRA:4K4, ETR:4K4, 4K4:GR |
| - |
| http://staybletherapeutic.. |
|
Stayble Therapeutics AB is a clinical-stage pharmaceutical company focused on developing innovative treatments for chronic low back pain, specifically targeting degenerative disc disease. The primary aim of Stayble's research is to provide a signific..
>Volltext.. |
| 1.12 Mio. EUR |
| 0.9 Mio. EUR |
| - |
| - |
| -0.65 Mio. EUR |
| -0.01 EUR |
| - |
| 0.23 Mio. EUR |
| -0.63 Mio. EUR |
| 2.89 |
| - |
| 40.88% |
| - |
| - |
| - |
| - |
| STAYBLE THERAPEUTICS, STAYBLE THERAPEUTIC |
| 05.04.26 |
|